Kyowa Kirin International has announced the appointment of Julie Dehaene-Puype as President for the Region, effective November 1, 2025. She succeeds Jeremy Morgan, who will transition to an advisory role. Julie brings over 25 years of experience in the global pharmaceutical industry.
Who to call at Kyowa Kirin International, and when
A new leader at Kyowa Kirin International brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Kyowa Kirin International raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Kyowa Kirin International, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kyowa Kirin International. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Kyowa Kirin International
Location
Galashiels, Scotland, United Kingdom
About
Kyowa Kirin International (KKI) is driven by a deep commitment to life, dedicated to addressing the unmet medical needs of patients, their families, and the healthcare professionals who support them. With a team of over 700 people, KKI is a rapidly growing specialty biopharmaceutical company focused on developing and commercializing innovative medicines in oncology, nephrology, and central nervous system (CNS) therapies across Europe and the Middle East.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kyowa Kirin International changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GalashielsBiotechnologyHealth CarePharmaceuticalpharmaceuticals